-
-
-
-
-
-
-
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
-
-
-
-
-
-
-
Aerie Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Thursday, February 24, 2022 at 5:00 p.m. ET
-
-
-
-
-
-
-
Aerie Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Aerie Pharmaceuticals Announces Novel Dry Eye Product Candidate AR-15512 (TRPM8 Agonist) Ophthalmic Solution Achieved Statistical Significance Over Multiple Symptoms and Signs in Successful Phase 2b C
-
-
-
-
-
-
-
Aerie Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Aerie Pharmaceuticals Announces Publication of Peer-Reviewed Paper Evaluating the Treatment Effect of Netarsudil on Outflow Function in Steroid-Induced Glaucoma
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

